尿路感染症に対するPiridazin-Meitoの使用経験
スポンサーリンク
概要
- 論文の詳細を見る
Measurement of concentration of a new sulfon a m ide, Piridazin-Meito (Sulfamethoxypyridazine), in the blood and the results of its clinical application have been reported. 1) Maximum concentrations of 10.6m g/dl and 19.8m g/dl of the drug i n the blood have been reached 6 hours after administrations of 1 gm and 2 gm once a day respectively. The concentrations of the drug in the blood 24 hours after the administration were still 7.5m g/di, 9.8 m g/d1. From these findings it is evident that this drug is long-acting with high concentration in the blood. 2) This drug was ad m inistered in doses of 0.5-1 gm or 1-2 gm a day by mouth to 21 cases of infection of the urinary tract, significant improvements were observed in 16 cases, improvement 3 cases and no change in 2 cases. No side reaction was observed.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績